ENVVENO MEDICAL CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.205 USD | -0.29% |
|
-5.36% | +1.26% |
Chart calendar enVVeno Medical Corporation
892bf51.ZkpLwWVgamiNjhOMqX-6Pkl0Yo_ThLa0E4Hcftq83oA.UTI7kgo5GRC69nL7nSfpVQ0EF_qZxcLha8OwSYLRhq02KzyOSFIbJcLKXg~cde70e6985e9f63ef6bb3bb2b5d8d4ac
Upcoming events on enVVeno Medical Corporation
Past events on enVVeno Medical Corporation
| 29/04/2024 | Q1 2024 Earnings Release (Projected) |
| 24/04/2024 | Charing Cross International Symposium - Dr. David Dexter |
| 07/03/2024 12:00 am | American Venous Forum |
| 05/12/2023 | Annual General Meeting |
| 16/11/2023 | VEITH Symposium |
| 26/10/2023 05:35 pm | Q3 2023 Earnings Release |
| 25/10/2023 09:30 pm | Investor Ask the CEO Conference |
| 02/08/2023 | Q2 2023 Earnings Release (Projected) |
| 19/07/2023 12:30 am | Investor Meeting - Key Opinion Leader |
| 13/07/2023 09:30 pm | Summer Spotlight Series Investor Conference |
| 01/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 08/03/2023 07:40 pm | Cowen Health Care Conference |
| 02/03/2023 | Q4 2022 Earnings Release |
| 19/01/2023 11:30 pm | Virtual Investor 2023 Companies to Watch |
| 30/11/2022 | Annual General Meeting |
| 11/11/2022 01:35 am | Q3 2022 Earnings Release |
| 29/09/2022 11:30 pm | Ladenburg Thalmann Healthcare Conference - Fireside Chat |
| 22/09/2022 02:00 am | Business Update Call |
| 12/09/2022 04:30 pm | H.C. Wainwright Global Investment Conference |
| 04/08/2022 02:15 am | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,03 0,03 0.77% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,68 -7,76 1.1% | -9,14 -7,04 -29.76% | -16,9 -12,6 -34.17% | -24,9 -25,2 1.14% | -25,2 -26,7 5.48% | -25,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,63 -7,72 1.21% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | -7,63 -7,72 1.21% | -9,74 -6,70 -45.41% | -16,5 -12,4 -33.4% | -24,7 -25,3 2.46% | -23,5 -26,1 9.8% | -26,1 |
|
EPS USD | Released Forecast Spread | -12,0 -12,3 2.04% | -7,54 -0,34 -2117.65% | -1,90 -1,37 -38.69% | -2,20 -2,21 0.45% | -1,91 -2,07 7.73% | -1,40 |
| Announcement Date | 18/03/20 | 31/03/21 | 28/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,60 |
|
EBIT Million USD | Released Forecast Spread | -8,99 -4,10 -119.32% | -5,34 -3,72 -43.41% | -6,99 -3,94 -77.31% | -6,15 -5,98 -2.86% | -6,46 -6,75 4.3% | -6,80 -6,38 -6.54% | -6,81 -6,55 -4.03% | -5,35 -6,44 16.94% | -6,28 -6,65 5.59% | -6,60 | -6,64 | -5,94 | -6,65 | -6,89 |
|
Net income Million USD | Released Forecast Spread | -8,99 -4,02 -123.58% | -5,33 -3,78 -41.01% | -7,06 -3,99 -76.99% | -6,10 -6,04 -0.94% | -6,18 -6,80 9.12% | -6,39 -6,44 0.75% | -6,47 -6,61 2.06% | -5,00 -6,49 22.94% | -5,65 -6,71 15.81% | -6,66 | -6,70 | -6,00 | -6,71 | -6,95 |
|
EPS USD | Released Forecast Spread | -0,94 -0,33 -184.85% | -0,47 -0,29 -62.07% | -0,63 -0,33 -90.91% | -0,54 -0,52 -3.85% | -0,55 -0,57 3.51% | -0,57 -0,48 -18.75% | -0,58 -0,49 -18.37% | -0,45 -0,48 6.25% | -0,32 -0,46 30.43% | -0,40 | -0,36 | -0,31 | -0,34 | -0,33 |
| Announcement Date | 28/03/22 | 29/04/22 | 03/08/22 | 27/10/22 | 02/03/23 | 28/04/23 | 31/07/23 | 26/10/23 | 29/02/24 | - | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for enVVeno Medical Corporation
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 01:31 am | MORPHOSYS AG: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 28/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVNO Stock
- Calendar enVVeno Medical Corporation
